These Five Biotech Stocks Ranked Among This UK-based Fund's Favorites
Cheyne Capital is one of the few non-U.S firms that we track in our database.
Infinity Pharmaceuticals Inc. (INFI)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Infinity Pharmaceuticals Inc. (INFI) and AbbVie Inc (ABBV) Stand Together Against Cancer
AbbVie Inc (NYSE:ABBV) will provide Infinity Pharmaceuticals Inc. (NASDAQ:INFI) with $275 million to fortify a new venture to develop new treatments for patients with blood cancer.
Theravance Inc (THRX): Are Hedge Funds Right About This Stock?
At the moment, there are many indicators investors can use to analyze stocks. Some of the most under-the-radar are hedge fund and insider trading activity.
Incyte Corporation (INCY): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
In the 21st century investor’s toolkit, there are many gauges shareholders can use to track their holdings. A couple of the best are hedge fund and insider trading sentiment.
Hedge Funds Aren't Crazy About Charles River Laboratories (CRL) Anymore
In today’s marketplace, there are dozens of gauges shareholders can use to watch stocks. A pair of the most innovative are hedge fund and insider trading movement.
What Hedge Funds Think About Infinity Pharmaceuticals Inc. (INFI)
In the financial world, there are many methods shareholders can use to track stocks. A couple of the most innovative are hedge fund and insider trading activity.
Is Questcor Pharmaceuticals Inc (QCOR) Going to Burn These Hedge Funds?
In today’s marketplace, there are a multitude of methods shareholders can use to watch stocks. A pair of the most under-the-radar are hedge fund and insider trading activity.
Keryx Biopharmaceuticals (KERX): Rare Diseases and Rare Drugs Could Mean Great Gains For You
The U.S. is the largest market of biotechnology products in the world.
Hedge Funds Have Bought The Pep Boys - Manny, Moe & Jack (PBY), Emulex Corporation (ELX), and More
After a hedge fund or other major investor acquires at least 5% of the outstanding shares of a public company or makes significant changes to that position, they file a 13D or 13G with the SEC.
Rigel Pharmaceuticals, Inc. (RIGL), Synta Pharmaceuticals Corp. (SNTA): Three Horrendous Health-Care Stocks This Week
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) announced results from a mid-stage clinical study this week for lung cancer drug ganetespib. Shares plunged 38% as investors reacted.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
